Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age

Abstract Objective To evaluate the safety and efficacy of intravenous golimumab + methotrexate (MTX) in patients with active rheumatoid arthritis (RA) aged < 65 years and those ≥ 65 years who were enrolled in the GO-FURTHER study. Methods In the phase III, double-blind, randomized, placebo-contro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: John Tesser, Shelly Kafka, Raphael J. DeHoratius, Stephen Xu, Elizabeth C. Hsia, Anthony Turkiewicz
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2019-08-01
Colecção:Arthritis Research & Therapy
Assuntos:
Rheumatoid arthritis
Geriatric
Anti-tumor necrosis factor
Golimumab
Acesso em linha:http://link.springer.com/article/10.1186/s13075-019-1968-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados